A Phase 2 study of TD-1473 in Crohn's disease.
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs TD 1473 (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 09 Feb 2018 New trial record
- 07 Feb 2018 According to a Theravance Biopharma media release, company plans to initiate the study in 2018.